![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Intellia Therapeutics Inc | NASDAQ:NTLA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.535 | 2.06% | 26.545 | 26.52 | 26.58 | 26.90 | 25.92 | 26.36 | 283,158 | 15:17:24 |
1
|
NAMES
OF REPORTING PERSONS
Caribou
Therapeutics Holdco, LLC
|
|||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
☐
|
|||
3
|
SEC USE
ONLY
|
|||
4
|
CITIZENSHIP OR
PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER
OF SHARES
|
5
|
SOLE
VOTING POWER
0
|
||
BENEFICIALLY
OWNED
BY
|
6
|
SHARED
VOTING POWER
1,807,841
|
||
EACH
REPORTING
|
7
|
SOLE
DISPOSITIVE POWER
0
|
||
PERSON
WITH:
|
8
|
SHARED
DISPOSITIVE POWER
1,807,841
|
||
9
|
AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,807,841
|
|||
10
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
☐
|
|||
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.0%
|
|||
12
|
TYPE OF
REPORTING PERSON
OO
|
1
|
NAMES
OF REPORTING PERSONS
Caribou
Biosciences, Inc.
|
|||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
☐
(b)
☐
|
|||
3
|
SEC USE
ONLY
|
|||
4
|
CITIZENSHIP OR
PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER
OF SHARES
|
5
|
SOLE
VOTING POWER
0
|
||
BENEFICIALLY
OWNED
BY
|
6
|
SHARED
VOTING POWER
1,807,841
|
||
EACH
REPORTING
|
7
|
SOLE
DISPOSITIVE POWER
0
|
||
PERSON
WITH:
|
8
|
SHARED
DISPOSITIVE POWER
1,807,841
|
||
9
|
AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,807,841
|
|||
10
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
☐
|
|||
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.0
%
|
|||
12
|
TYPE OF
REPORTING PERSON
HC
|
|
|
Date: March 25,
2019
|
CARIBOU
THERAPEUTICS HOLDCO, LLC
BY:
CARIBOU BIOSCIENCES, INC.,
ITS
MANAGER
By:
/s/ Rachel E.
Haurwitz
Name: Rachel
E. Haurwitz
Title:
President and Chief Executive Officer
|
|
|
Date: March 25,
2019
|
CARIBOU
BIOSCIENCES, INC.
By:
/s/ Rachel E.
Haurwitz
Name: Rachel
E. Haurwitz
Title:
President and Chief Executive Officer
|
|
1 Year Intellia Therapeutics Chart |
1 Month Intellia Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions